SRR and Alzheimer disease: SRR, an enzyme for catalyzing the conversion of L-serine to D-serine (an essential co-agonist of the NMDA receptor) [15], was up-regulated by more than two folds in AD (Additional file 2: Table S2), which may lead to over-activated NMDA receptors, thereby contributing to AD pathophysiology.